An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 065275
Company: HIKMA

Products on ANDA 065275

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
IDARUBICIN HYDROCHLORIDE	IDARUBICIN HYDROCHLORIDE	1MG/ML	INJECTABLE;INJECTION	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 065275

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
12/14/2006	ORIG-1	Approval				Label is not available on this site.

Therapeutic Equivalents for ANDA 065275

IDARUBICIN HYDROCHLORIDE

INJECTABLE;INJECTION; 1MG/ML
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
IDAMYCIN PFS	IDARUBICIN HYDROCHLORIDE	1MG/ML	INJECTABLE;INJECTION	Prescription	Yes	AP	050734	PFIZER
IDARUBICIN HYDROCHLORIDE	IDARUBICIN HYDROCHLORIDE	1MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	065275	HIKMA
IDARUBICIN HYDROCHLORIDE	IDARUBICIN HYDROCHLORIDE	1MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	065288	HIKMA
IDARUBICIN HYDROCHLORIDE	IDARUBICIN HYDROCHLORIDE	1MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	065036	MEITHEAL

Top